Skip to main content

Grantham, Mayo, Van Otterloo & Co. LLC

SEC CIK
0001352662
Latest filing
Aug 13, 2026

NVS holding history

Novartis AG in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
245,957
Value
$38.5M
% of portfolio
0.1%
Quarters held
19
Since Q2 2021
Holdings of NVS by Grantham, Mayo, Van Otterloo & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026245,957$38.5M0.1%−29,680−10.8%ReducedHolders
Q1 2026275,637$42.1M0.1%−23,538−7.9%ReducedHolders
Q4 2025299,175$41.2M0.1%−31,857−9.6%ReducedHolders
Q3 2025331,032$42.5M0.1%−21,663−6.1%ReducedHolders
Q2 2025352,695$42.7M0.1%−39,456−10.1%ReducedHolders
Q1 2025392,151$43.7M0.1%−185,750−32.1%ReducedHolders
Q4 2024577,901$56.2M0.2%−87,118−13.1%ReducedHolders
Q3 2024665,019$76.5M0.2%−114,662−14.7%ReducedHolders
Q2 2024779,681$83.0M0.3%−166,195−17.6%ReducedHolders
Q1 2024945,876$91.5M0.3%−581,499−38.1%ReducedHolders
Q4 20231,527,375$154.2M0.7%−299,888−16.4%ReducedHolders
Q3 20231,827,263$186.1M0.9%+1,144,307+167.6%AddedHolders
Q2 2023682,956$68.9M0.3%+672,756+6,595.6%AddedHolders
Q1 202310,200$938.4K<0.1%−34,800−77.3%ReducedHolders
Q4 202245,000$4.08M<0.1%+45,000NewHolders
Q2 20220$00.0%−3,500−100.0%Sold outHolders
Q1 20223,500$307.0K<0.1%−192,200−98.2%ReducedHolders
Q4 2021195,700$17.1M0.1%+32,800+20.1%AddedHolders
Q3 2021162,900$13.3M0.1%+159,900+5,330.0%AddedHolders
Q2 20213,000$274.0K<0.1%+3,000NewHolders